,[30], [31], [32] Of note, the S1P–S1P receptor (S1PR) pathway is a driver of multiple inflammatory diseases (e.g. multiple sclerosis, ulcerative colitis, and rheumatoid arthritis), and there is already a S1PR-targeted drug available.30 This evidence concerns the gene MBTPS1 and ulcerative colitis.